Prophylactic peritoneal dialysis catheter does not decrease time to achieve a negative fluid balance after the Norwood procedure: a randomized controlled trial
Lindsay M Ryerson, Andrew S Mackie, Joseph Atallah, Ari R Joffe, Ivan M Rebeyka, David B Ross, Ian Adatia, Lindsay M Ryerson, Andrew S Mackie, Joseph Atallah, Ari R Joffe, Ivan M Rebeyka, David B Ross, Ian Adatia
Abstract
Objective: Infants and children who undergo cardiopulmonary bypass and cardiac surgery are at risk of postoperative fluid overload. Peritoneal dialysis catheter (PDC) and peritoneal dialysis are reported to be effective means of postoperative fluid management. We sought to test the hypothesis that PDC insertion in the operating room at the time of Norwood palliation would decrease the time to achieve a negative fluid balance in a group of neonates with hypoplastic left heart syndrome.
Methods: A single center randomized controlled trial was performed. We randomized neonates with hypoplastic left heart syndrome to prophylactic PDC, with or without dialysis, or standard care (ie, no PDC).
Results: Twenty-two neonates were included; 10 were randomized to PDC and 12 were randomized to standard care. The mean time to first postoperative negative fluid balance was 2.70 ± 1.06 days for the prophylactic PDC group and 2.67 ± 0.65 days for the standard care group (P = .93). There was no difference between the 2 groups in time to lactate ≤ 2 mmol/L, maximum vasoactive-inotrope score on postoperative days 2 to 5, time to sternal closure, time to first extubation, modified clinical outcome score, or hospital length of stay. Twenty-one patients (95%) survived to hospital discharge. Four patients randomized to prophylactic PDC had 1 or more serious adverse events compared with no patients in the standard care group (P = .03).
Conclusions: Prophylactic PDC, with or without dialysis, did not decrease the time to achieve a negative fluid balance after the Norwood procedure, did not alter physiological variables postoperatively, and was associated with more severe adverse events.
Trial registration: ClinicalTrials.gov NCT01215240.
Copyright © 2015 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Source: PubMed
即将进行的临床试验
-
Sohag University尚未招聘
-
Stanford University尚未招聘
-
Tianjin Eye Hospital招聘中
-
Neuralink Corp招聘中
-
National Institute of Diabetes and Digestive and...尚未招聘
-
National Heart, Lung, and Blood Institute (NHLBI)尚未招聘
-
National Cancer Institute (NCI)尚未招聘非小细胞肺癌 | 非小细胞肺癌 | 肺癌 | 前列腺癌 | mCRPC | 转移性去势抵抗性前列腺癌 | 胸腺上皮肿瘤 | TETs | Thymic Carcinomas | Thymomas美国
-
National Institute of Dental and Craniofacial Research...尚未招聘肥胖 | 阻塞性睡眠呼吸暂停 (OSA) | 上颌发育不全 | 下颌发育不全 | Pediatric Obstructive Sleep Apnea (OSA) | Adeno-Tonsillar Hypertrophy | Intraoral Appliance美国
-
National Institute of Allergy and Infectious Diseases...尚未招聘
-
National Heart, Lung, and Blood Institute (NHLBI)尚未招聘肥厚型心肌病 | Left Ventricular Outflow Obstruction | Systolic Anterior Motion美国
-
National Institute of Neurological Disorders and...尚未招聘